The Consolidated Appropriations Act, 2021, signed by President Trump on December 27, 2020, included within its over 5,900 pages the controversial and long-debated No Surprises Act (the Act), addressing surprise medical bills....more
Over the past several weeks, many states have shifted their focus from concerns around restricting business and activity due to increasing numbers of COVID-19 cases to resuming some limited and vital activities as COVID-19...more
On May 13, 2020, Paul R. Rodríguez, New Jersey’s Acting Director of the Division of Consumer Affairs, issued an Administrative Order permitting licensed pharmacists in New Jersey to order and administer testing for COVID-19....more
Over the past few weeks, the focus of the COVID-19 pandemic has shifted towards the reopening of businesses, including resuming non-emergent health care postponed under prior guidance. The initial stages of COVID-19 created...more
On April 19, 2020, the Centers for Medicare and Medicaid Services (CMS) released recommendations for resuming non-emergent, non-COVID-19 health care services in regions with low and stable incidence of COVID-19 (the...more
Philip Murphy, governor of New Jersey, signed Executive Order No. 112 on April 1, 2020, authorizing the New Jersey Division of Consumer Affairs (the DCA) to temporarily reactivate the licenses of recently retired health care...more
On March 19, 2020, New Jersey Governor Phil Murphy signed two bills into law, A-3860 and A-3862, which expand access to telehealth services during the COVID-19 public health emergency. In addition, A-3862 allows professional...more
The Centers for Medicare & Medicaid Services (CMS) released Quality, Safety & Oversight Group guidance for infection control and prevention concerning coronavirus disease 2019 (COVID-19) for all Medicare and Medicaid...more